High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination

Clinical and Experimental Immunology

Volumn 155, Issue 3, 2009, Pages 441-446

  Wang, M ^b   Tang, S T ^d   Lund, O ^d   Dziegiel, M H ^c   Buus, S ^b   Claesson, M H ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

HLA class I; HLA class II; Peptide; Smallpox virus; Vaccine

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNOLOGICAL MEMORY; MALE; POXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINATION; VACCINIA VIRUS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROTEIN BINDING; TIME FACTORS; VACCINATION; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 59249096068     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03856.x     Document Type: Article

References (23)

1. Larsen MV, Lundegaard C, Lamberth K et al. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005 35 : 2295 303.
2. Sylvester-Hvid C, Kristensen N, Blicher T et al. Establishment of a quantitative ELISA capable of determining peptide-MHC class I interaction. Tissue Antigens 2002 59 : 251 8.
3. Sylvester-Hvid C, Nielsen M, Lamberth K et al. SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens 2004 63 : 395 400.
4. Tang ST, Wang M, Lamberth K et al. MHC I restricted epitopes conserved among variola and other related orthopoxviruses are recognised by T cells 30 years after vaccination. Arch Virol 2008 153 : 1833 44.
5. Wang M, Lamberth K, Harndahl M et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007 25 : 2823 31.
6. Ostergaard PL, Nissen MH, Hansen NJ et al. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol 2001 31 : 2986 96.
7. Hammond AS, Klein MR, Corrah T et al. Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes. Clin Exp Immunol 2005 140 : 109 16.
8. Alter G, Merchant A, Tsoukas CM et al. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J Infect Dis 2002 185 : 755 65.
9. Brice GT, Graber NL, Carucci DJ, Doolan DL. Optimal induction of antigen-specific CD8+ T cell responses requires bystander cell participation. J Leukoc Biol 2002 72 : 1164 71.
10. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999 17 : 51 88.
11. Lauemoller SL, Kesmir C, Corbet SL et al. Identifying cytotoxic T cell epitopes from genomic and proteomic information: 'the human MHC project'. Rev Immunogenet 2000 2 : 477 91.
12. Boyle LH, Goodall JC, Opat SS, Gaston JS. The recognition of HLA-B27 by human CD4(+) T lymphocytes. J Immunol 2001 167 : 2619 24.
13. Boyle LH, Hill Gaston JS. Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies. Rheumatology (Oxf) 2003 42 : 404 12.
14. Boyle LH, Goodall JC, Gaston JS. The recognition of abnormal forms of HLA-b27 by CD4+ T cells. Curr Mol Med 2004 4 : 51 8.
15. Darrow TL, bdel-Wahab Z, Quinn-Allen MA, Seigler HF. Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2. Cell Immunol 1996 172 : 52 9.
16. Kobayashi H, Kimura S, Aoki N, Sato K, Celis E, Katagiri M. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Immunogenetics 2001 53 : 626 33.
17. Moore RL, Fox BS. CD4+ class I-restricted T cells specific for HIV gp160 315-329. Cell Immunol 1994 154 : 43 53.
18. Chicz RM, Urban RG, Lane WS et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992 358 : 764 8.
19. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991 353 : 622 7.
20. York IA, Goldberg AL, Mo XY, Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 1999 172 : 49 66.
21. Lammermann T, Sixt M. The microanatomy of T-cell responses. Immunol Rev 2008 221 : 26 43.
22. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998 19 : 395 404.
23. Wilson DB, Wilson DH, Schroder K et al. Specificity and degeneracy of T cells. Mol Immunol 2004 40 : 1047 55.